Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
18,233
Total Claims
$1.5M
Drug Cost
2,037
Beneficiaries
$747
Cost/Patient
Risk Score Breakdown 6/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-47%
Cost per patient vs peers
$747 vs $1,411 avg
-10%
Brand preference vs peers
9.5% vs 10.6% avg
Brand vs Generic
Brand: 1,730 claims · $1.1M
Generic: 16,400 claims · $380K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 207 | $310K |
| Sitagliptin Phosphate | 80 | $134K |
| Semaglutide | 50 | $101K |
| Rivaroxaban | 44 | $68K |
| Insulin Glargine,hum.Rec.Anlog | 37 | $32K |
| Empagliflozin | 17 | $30K |
| Sitagliptin Phos/Metformin Hcl | 12 | $19K |
| Atorvastatin Calcium | 1,483 | $19K |
| Fluticasone Propion/Salmeterol | 23 | $19K |
| Levothyroxine Sodium | 1,081 | $18K |
| Mirabegron | 13 | $17K |
| Insulin Aspart | 11 | $14K |
| Losartan Potassium | 828 | $13K |
| Rosuvastatin Calcium | 583 | $12K |
| Omeprazole | 607 | $8,008 |
Prescribing Profile
Patient Profile
76
Avg Age
53%
Female
1.22
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data